{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:45:25Z","timestamp":1778924725498,"version":"3.51.4"},"reference-count":8,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","annalsthoracicsurgery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Annals of Thoracic Surgery"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.athoracsur.2020.09.083","type":"journal-article","created":{"date-parts":[[2020,12,26]],"date-time":"2020-12-26T15:52:27Z","timestamp":1608997947000},"page":"e53-e55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Salvage Surgery Post Definitive Chemoradiotherapy and Durvalumab for Lung Cancer"],"prefix":"10.1016","volume":"112","author":[{"given":"Kentaro","family":"Minegishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyoshi","family":"Tsubochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenjiro","family":"Komori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.athoracsur.2020.09.083_bib1","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athoracsur.2020.09.083_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.semtcvs.2017.02.001","article-title":"Salvage surgery after definitive chemoradiotherapy for non-small lung cancer","volume":"29","author":"Casiraghi","year":"2017","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2020.09.083_bib3","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.athoracsur.2019.06.087","article-title":"Salvage surgery after chemotherapy or chemoradiotherapy for initially unresectable lung carcinoma","volume":"108","author":"Sonobe","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2020.09.083_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.lungcan.2019.05.010","article-title":"Salvage surgery after definitive chemo-radiotherapy for patients with\u00a0non-small cell lung cancer","volume":"133","author":"Romero-Vielva","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.athoracsur.2020.09.083_bib5","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.athoracsur.2020.04.035","article-title":"Salvage lung resections after definitive chemoradiotherapy: a safe and effective oncologic option","volume":"110","author":"Bograd","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2020.09.083_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jtho.2019.10.002","article-title":"Three-year overall survival with durvalumab after chemoradiotherapy in stage III NSCLC\u2014Update from PACIFIC","volume":"15","author":"Gray","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2020.09.083_bib7","doi-asserted-by":"crossref","first-page":"24801","DOI":"10.18632\/oncotarget.24835","article-title":"Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis","volume":"9","author":"Soo","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.athoracsur.2020.09.083_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejca.2015.11.020","article-title":"Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy","volume":"55","author":"Tokito","year":"2016","journal-title":"Eur J Cancer"}],"container-title":["The Annals of Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497520321706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497520321706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T17:55:06Z","timestamp":1716227706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003497520321706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0003497520321706"],"URL":"https:\/\/doi.org\/10.1016\/j.athoracsur.2020.09.083","relation":{},"ISSN":["0003-4975"],"issn-type":[{"value":"0003-4975","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvage Surgery Post Definitive Chemoradiotherapy and Durvalumab for Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"The Annals of Thoracic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athoracsur.2020.09.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The Society of Thoracic Surgeons Published by Elsevier","name":"copyright","label":"Copyright"}]}}